Image credit: Ben Schumin

Cannabis Lobbying Spend Remains Flat, Despite Momentum Behind Federal Reform

There are more companies and groups lobbying on cannabis than ever before, but spending has yet to rebound from a 2020 decline.

Lobbying
New York

New York: Cannabis and the Cuomo Effect

While Cuomo’s scandals might have helped push legalization over the finish line in 2021, the latest fallout could cause delays in setting up the industry.

CBD

Cannabis and Clinical Trials: How the First Cannabis Extract Got FDA Approval

CSU Pueblo hosted a pharmacist at Greenwich Biosciences to talk about the company’s path with Epidiolex, a CBD-based medicine extracted from cannabis plants.